Pejman Rowshanfarzad Selected Research

Fibrosarcoma

3/2009	Preclinical studies of [61Cu]ATSM as a PET radiopharmaceutical for fibrosarcoma imaging.
1/2007	Production and tumour uptake of [64Cu]Pyruvaldehyde-bis (N4-methylthiosemicarbazone) for PET and/or therapeutic purposes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pejman Rowshanfarzad Research Topics

Disease

7	Neoplasms (Cancer) 01/2024 - 01/2007
5	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 12/2022
4	AIDS-Related Complex (ARC) 01/2015 - 06/2012
3	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 12/2021
2	Fibrosarcoma 03/2009 - 01/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Disease Progression 01/2021

Drug/Important Bio-Agent (IBA)

3	Tyrosine (L-Tyrosine)FDA Link 04/2024 - 12/2021
3	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2021
2	RadiopharmaceuticalsIBA 03/2009 - 01/2007
1	N-(3,4,5-trichlorophenyl)succinimideIBA 01/2024
1	Amino Acids FDA Link 12/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Zinc-68IBA 01/2007
1	Acetates (Acetic Acid Esters)FDA Link 01/2007
1	LigandsIBA 01/2007
1	copper pyruvaldehyde bis(N(4)-methylthiosemicarbazone) complexIBA 01/2007

Therapy/Procedure

8	Radiotherapy 01/2024 - 06/2012
2	Therapeutics 01/2014 - 01/2007
1	Proton Therapy 01/2023